{
 "generic_name": "Rifampin Injection",
 "slug": "rifampin-injection",
 "brand_names": [
  "Rifadin Iv",
  "Rifampin"
 ],
 "fda_status": [
  "Current"
 ],
 "last_fda_update": "09/18/2026",
 "first_posted": "02/17/2021",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Mylan Institutional, a Viatris Company",
   "package_ndc": "67457-445-60",
   "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: Q4 2026"
  },
  {
   "company": "Sanofi-Aventis U.S. LLC",
   "package_ndc": "0068-0597-01",
   "presentation": "Rifadin, Injection, 600 mg (NDC 0068-0597-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Discontinuation of the manufacture of the drug"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-351-20",
   "presentation": "Rifampin, Injection, 600 mg (NDC 63323-351-20)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Check wholesalers for inventory"
  }
 ],
 "changes": []
}